GlassScriptPhysician profile
Xinrong Lu
NPI 1164683447
$24,018.98
in general payments reported to CMS, 2019-2025
16 companies · $2,193 in 2025
The $2,193 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $7,292 · 2021: $8,090 · 2022: $4,759 · 2023: $793 · 2024: $505 · 2025: $2,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,750 · Food and Beverage: $1,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,750.00 |
| Food and Beverage | $1,740.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $9,367.25 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $4,162.59 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $4,102.60 | 2020-2021 | |
| Abbvie INC. | $3,760.20 | 2021-2025 | |
| Pfizer INC. | $1,832.12 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $190.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $152.87 | 2019 | |
| Neurelis, INC. | $105.43 | 2023 | Valtoco |
| Averitas Pharma INC. | $105.40 | 2023 | Qutenza |
| Lundbeck LLC | $89.16 | 2021-2025 | Vyepti |
| Medtronic, INC. | $45.16 | 2024 | Linq II |
| Merz North America, INC. | $27.07 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.34 | 2022 | |
| Upsher-Smith Laboratories LLC | $21.62 | 2021 | |
| Janssen Biotech, INC. | $18.57 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xinrong Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.